Impact of Duration of Untreated Manic Episodes on Clinical Outcome

Sponsor
Assiut University (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT04563910
Collaborator
(none)
100
1
13
7.7

Study Details

Study Description

Brief Summary

The current study is cross sectional retrospective study, included 100 patients were diagnosed as mood disorder bipolar I (manic episodes) according to DSM5, patients recruited from inpatient psychiatric unit at department of Neurology and Psychiatry, Assiut University hospitals The current work is designed to study the effect of duration of untreated bipolar disorder on clinical outcome ( severity , residual symptoms ,duration of hospital admission) and to study factors affecting duration of untreatment in Upper Egypt.

Condition or Disease Intervention/Treatment Phase
  • Other: young mania rating scale

Detailed Description

Mood disorder carries a major burden in our country as it represents 15% of inpatients and 20% of outpatients in mental hospitals in Egypt

The current work is designed to study the effect of duration of untreated bipolar disorder on clinical outcome ( severity , residual symptoms ,duration of hospital admission) and to study factors affecting duration of untreatment in Upper Egypt.

The current study is cross sectional retrospective study, included 100 patients were diagnosed as mood disorder bipolar I (manic episodes) according to DSM5, patients recruited from inpatient psychiatric unit at department of Neurology and Psychiatry, Assiut University hospitals

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Case-Only
Time Perspective:
Cross-Sectional
Official Title:
Impact of Duration of Untreated Bipolar Disorder (Manic Episodes) on Clinical Outcome
Anticipated Study Start Date :
Sep 23, 2020
Anticipated Primary Completion Date :
Sep 23, 2021
Anticipated Study Completion Date :
Oct 24, 2021

Arms and Interventions

Arm Intervention/Treatment
less than 2 episodes

Patients were classified into 3 groups according to number of episodes (1-2 episodes, 3-5 episodes, more than 5 episodes)

Other: young mania rating scale
questionnaires to the patients and their family after their written consent
Other Names:
  • socioeconomic scale
  • 2-5 episodes

    Patients were classified into 3 groups according to number of episodes (1-2 episodes, 3-5 episodes, more than 5 episodes)

    Other: young mania rating scale
    questionnaires to the patients and their family after their written consent
    Other Names:
  • socioeconomic scale
  • more than 5 episodes

    Patients were classified into 3 groups according to number of episodes (1-2 episodes, 3-5 episodes, more than 5 episodes)

    Other: young mania rating scale
    questionnaires to the patients and their family after their written consent
    Other Names:
  • socioeconomic scale
  • Outcome Measures

    Primary Outcome Measures

    1. measure the effect of duration of untreated bipolar disorder on severity (young mania rating scale on admission [one year]

      To study the effect of duration of untreated bipolar disorder (manic episodes) on clinical outcomes (severity).

    Secondary Outcome Measures

    1. To measure the effect of duration of untreated bipolar disorder (manic episodes) on clinical outcomes (severity, residual symptoms, duration of admission). [one year]

      residual symptoms measured by young mania rating scale on discharge

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 45 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • -Age group between 18 to 45 years old.

    • Patients diagnosed as mood disorder bipolar I manic episode according to DSM V(2).

    • Clearly consenting to participate in the study.

    Exclusion Criteria:
    • -Mood disorder due to substance abuse.

    • Patients in depressive episodes.

    • other mental disorders

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Assiut university Assiut Egypt

    Sponsors and Collaborators

    • Assiut University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Maggi Raoof, Maggi Raoof Samaan, Assiut University
    ClinicalTrials.gov Identifier:
    NCT04563910
    Other Study ID Numbers:
    • 17101199
    First Posted:
    Sep 25, 2020
    Last Update Posted:
    Sep 25, 2020
    Last Verified:
    Sep 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 25, 2020